CERUS CORP (CERS) Stock News

USA - NASDAQ:CERS - US1570851014 - Common Stock

1.71 USD

+0.3 (+21.28%)

Last: 11/7/2025, 8:00:00 PM

1.72 USD

+0.01 (+0.58%)

Pre-Market: 11/10/2025, 5:47:17 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CERS Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Benzinga - Mentions: OPRX WORX IRD CMND ...

12 Health Care Stocks Moving In Thursday's After-Market Session

4 days ago - By: Cerus Corporation

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

4 days ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

20 days ago - By: Cerus Corporation

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

25 days ago - By: Cerus Corporation

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

3 months ago - By: Cerus Corporation

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

3 months ago - By: Cerus Corporation

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

3 months ago - By: Cerus Corporation

Cerus Corporation Announces Second Quarter 2025 Financial Results

4 months ago - By: Cerus Corporation

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

4 months ago - By: Cerus Corporation

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

4 months ago - By: Cerus Corporation

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

5 months ago - By: Cerus Corporation

Cerus Corporation Celebrates World Blood Donor Day 2025

5 months ago - By: Cerus Corporation

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

5 months ago - By: Cerus Corporation

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

6 months ago - By: Cerus Corporation

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

6 months ago - By: Zacks Investment Research - Mentions: BTMD

Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Cerus Corporation

Cerus Corporation Announces First Quarter 2025 Financial Results

7 months ago - By: Cerus Corporation

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

8 months ago - By: Cerus Corporation

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

9 months ago - By: Cerus Corporation

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

9 months ago - By: Cerus Corporation

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

9 months ago - By: Cerus Corporation

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

10 months ago - By: Cerus Corporation

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

a year ago - By: Cerus Corporation

Cerus Corporation to Participate in Upcoming Investor Conferences

a year ago - By: Cerus Corporation

Cerus Corporation Announces Third Quarter 2024 Financial Results

a year ago - By: Cerus Corporation

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

a year ago - By: Cerus Corporation

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting